---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-027972"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:11:43.296457+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# China Pharma regains NYSE American compliance after reverse stock split

## Summary
- Received NYSE American notice on March 27, 2024 confirming compliance with continued listing standards.
- Resolved low selling price deficiency (Section 1003(f)(v)) via 1-for-5 reverse stock split on March 6, 2024.
- ".BC" indicator to be removed; company removed from noncompliant issuers list.
- NYSE American cautioned that no cure period exists if stock again trades at abnormally low levels.

## SEC filing metadata
- accession: 0001213900-24-027972
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/0001213900-24-027972-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/ea0202916-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-027972
- JSON: https://secwatch.observer/filing/0001213900-24-027972.json
- Plain text: https://secwatch.observer/filing/0001213900-24-027972.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.